CTMX
CytomX Therapeutics Inc
Price:  
1.18 
USD
Volume:  
586,372.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTMX WACC - Weighted Average Cost of Capital

The WACC of CytomX Therapeutics Inc (CTMX) is 6.8%.

The Cost of Equity of CytomX Therapeutics Inc (CTMX) is 8.85%.
The Cost of Debt of CytomX Therapeutics Inc (CTMX) is 5.00%.

Range Selected
Cost of equity 7.40% - 10.30% 8.85%
Tax rate 0.20% - 12.10% 6.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 7.4% 6.8%
WACC

CTMX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.78 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.30%
Tax rate 0.20% 12.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 7.4%
Selected WACC 6.8%